Donor Diabetes and Steatosis Affects Recipient Survival Following Liver Transplantation Based on Etiology of Liver Cirrhosis.

BACKGROUND Liver transplantation (LT) offers patients with decompensated cirrhosis the best chance at long-term survival. With the rising prevalence of diabetes, further clarity is needed on the impact of receiving a liver allograft from a donor with diabetes on post-LT outcomes. This study aims to evaluate the impact of donor diabetes on clinical outcomes after LT. METHODS This is a retrospective analysis of the United Network for Organ Sharing registry data of LT recipients from January 1, 2000, to December 31, 2021. Outcomes analysis was performed using Cox proportional model for all-cause mortality and graft failure. Confounding was reduced by coarsened exact matching causal inference analysis. RESULTS Of 66 960 donors identified, 7178 (10.7%) had diabetes. Trend analysis revealed a longitudinal increase in the prevalence of donor diabetes (P < 0.001). Importantly, donor diabetes was associated with increased all-cause mortality (hazard ratio [HR]: 1.13; 95% confidence interval [CI], 1.07-1.19; P < 0.001) and graft failure (HR: 1.16; 95% CI, 1.11-1.22; P < 0.001). Receiving donor organ with diabetes reduced graft survival in patients who received LT for nonalcoholic steatohepatitis cirrhosis (HR: 1.26; 95% CI, 1.13-1.41; P < 0.001) but not other etiologies of cirrhosis. CONCLUSIONS Donor diabetes was associated with worse outcomes post-LT, particularly in patients receiving LT for nonalcoholic steatohepatitis cirrhosis. Future studies are needed to better understand the mechanism underlying this association to develop better risk stratification and clinical practice to improve the outcomes of the transplanted patients.

[1]  N. Syn,et al.  Mortality Outcomes by Fibrosis Stage in Non-alcoholic Fatty Liver Disease. A Systematic Review and Meta-Analysis. , 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  A. Luft,et al.  Endovascular Treatment for Acute Ischemic Stroke With or Without General Anesthesia: A Matched Comparison , 2022, Stroke.

[3]  A. Sanyal,et al.  Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals , 2022, Clinical and molecular hepatology.

[4]  Saleh Elwir,et al.  Factors impacting survival in those transplanted for NASH cirrhosis: Data from the NailNASH Consortium. , 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  N. Syn,et al.  Outcomes of Non-alcoholic Steatohepatitis following Liver Transplantation. An Updated Meta-analysis and Systematic Review. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  B. van Hoek,et al.  Donor diabetes mellitus is a risk factor for diminished outcome after liver transplantation: a nationwide retrospective cohort study , 2020, Transplant international : official journal of the European Society for Organ Transplantation.

[7]  J. Goss,et al.  Trends in Outcomes for Marginal Allografts in Liver Transplant. , 2020, JAMA surgery.

[8]  M. Stepanova,et al.  Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in the United States. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  A. Singal,et al.  Alcohol-associated Cirrhosis and Alcoholic Hepatitis Hospitalization Trends in the United States , 2020, Journal of clinical gastroenterology.

[10]  T. H. Nguyen,et al.  The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The lancet. Gastroenterology & hepatology.

[11]  R. DeMatteo,et al.  Association of Overlapping, Nonconcurrent, Surgery With Patient Outcomes at a Large Academic Medical Center: A Coarsened Exact Matching Study. , 2019, Annals of surgery.

[12]  Z. Younossi,et al.  The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis. , 2019, Journal of hepatology.

[13]  Yan Liu,et al.  Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis , 2019, Scientific Reports.

[14]  M. Siddiqui,et al.  The Interplay Between Nonalcoholic Fatty Liver Disease and Atherosclerotic Heart Disease , 2019, Hepatology.

[15]  K. Huybrechts,et al.  Implications of the Propensity Score Matching Paradox in Pharmacoepidemiology , 2018, American journal of epidemiology.

[16]  A. Sanyal,et al.  Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis , 2017, Transplantation.

[17]  A. Sanyal,et al.  De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  A. Sanyal,et al.  Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  A. Dare,et al.  Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review , 2015, Journal of Gastrointestinal Surgery.

[20]  L. Pasea,et al.  Analysis of ischemia/reperfusion injury in time‐zero biopsies predicts liver allograft outcomes , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[21]  Weilin Wang,et al.  Liver Grafts for Transplantation from Donors with Diabetes: An Analysis of the Scientific Registry of Transplant Recipients Database , 2014, PloS one.

[22]  R. Freeman Deceased donor risk factors influencing liver transplant outcome , 2013, Transplant international : official journal of the European Society for Organ Transplantation.

[23]  Jinbo Chen,et al.  Assessing the fit of parametric cure models. , 2013, Biostatistics.

[24]  A. Barritt,et al.  Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25]  K. Höckerstedt,et al.  Long-Term Results of Liver Transplantation , 2011, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[26]  K. Watt,et al.  Metabolic syndrome and liver transplantation: a review and guide to management. , 2010, Journal of hepatology.

[27]  G. King,et al.  Cem: Coarsened Exact Matching in Stata , 2009 .

[28]  G. Marchesini,et al.  Metabolic syndrome in liver transplantation: Relation to etiology and immunosuppression , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[29]  M. Berenguer Risk of extended criteria donors in hepatitis C virus–positive recipients , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.